Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NeoImmuneTech receives FDA orphan drug designation for NT-I7 to treat Progressive Multifocal Leukoencephalopathy
The US FDA’s Center for Drug Evaluation and Research. (Credit: The U.S. Food and Drug Administration)
The US FDA’s Center for Drug Evaluation and Research. (Credit: The U.S. Food and Drug Administration)